Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 174

1.

The short-term role of corticosteroid therapy for pulmonary arterial hypertension associated with connective tissue diseases: report of five cases and a literature review.

Kato M, Kataoka H, Odani T, Fujieda Y, Otomo K, Oku K, Horita T, Yasuda S, Atsumi T, Ohira H, Tsujino I, Nishimura M, Koike T.

Lupus. 2011 Oct;20(10):1047-56. doi: 10.1177/0961203311403347. Epub 2011 Jun 15. Review.

PMID:
21676917
2.

Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases.

Jais X, Launay D, Yaici A, Le Pavec J, Tchérakian C, Sitbon O, Simonneau G, Humbert M.

Arthritis Rheum. 2008 Feb;58(2):521-31. doi: 10.1002/art.23303.

3.

2009 ESC/ERS pulmonary hypertension guidelines and connective tissue disease.

Nakanishi N; European Society of Cardiology; European Respiratory Society.

Allergol Int. 2011 Dec;60(4):419-24. doi: 10.2332/allergolint.11-RAI-0362. Epub 2011 Oct 25. Review.

4.

Sildenafil for pulmonary arterial hypertension associated with connective tissue disease.

Badesch DB, Hill NS, Burgess G, Rubin LJ, Barst RJ, Galiè N, Simonneau G; SUPER Study Group.

J Rheumatol. 2007 Dec;34(12):2417-22. Epub 2007 Nov 1.

PMID:
17985403
5.

Pulmonary arterial hypertension complicating connective tissue diseases.

Hassoun PM.

Semin Respir Crit Care Med. 2009 Aug;30(4):429-39. doi: 10.1055/s-0029-1233312. Epub 2009 Jul 24. Review.

PMID:
19634082
6.

Pulmonary arterial hypertension: a rare complication of primary Sjögren syndrome: report of 9 new cases and review of the literature.

Launay D, Hachulla E, Hatron PY, Jais X, Simonneau G, Humbert M.

Medicine (Baltimore). 2007 Sep;86(5):299-315. Review.

7.

[Pulmonary arterial hypertension related to connective tissue diseases].

Pehlivan O, Inanç M.

Anadolu Kardiyol Derg. 2010 Aug;10 Suppl 1:57-62. doi: 10.5152/akd.2010.120. Review. Turkish.

8.

[Management of borderline pulmonary arterial hypertension associated with connective tissue diseases].

Yoshifuji H, Kinoshita H.

Nihon Rinsho Meneki Gakkai Kaishi. 2014;37(6):454-61. doi: 10.2177/jsci.37.454. Review. Japanese.

9.

Pulmonary capillary endothelial metabolic dysfunction: severity in pulmonary arterial hypertension related to connective tissue disease versus idiopathic pulmonary arterial hypertension.

Langleben D, Orfanos SE, Giovinazzo M, Hirsch A, Baron M, Senécal JL, Armaganidis A, Catravas JD.

Arthritis Rheum. 2008 Apr;58(4):1156-64. doi: 10.1002/art.23405.

10.

[Pulmonary arterial hypertension in connective tissue disease].

Cottin V.

Rev Mal Respir. 2006 Sep;23(4 Suppl):13S61-72. Review. French.

PMID:
17057632
11.

[The clinical analysis of pulmonary arterial hypertension in connective tissue disease].

Ji YQ, Zhang ZL, Lu WX.

Zhonghua Nei Ke Za Zhi. 2006 Jun;45(6):467-71. Chinese.

PMID:
16831323
12.

[Two-years therapy with bosentan of pulmonary arterial hypertension related to connective tissue diseases].

Marotta H, Montisci R, Tiso F, Pontarollo S, Rizzo M, Tona F, Iliceto S, Cozzi F.

Reumatismo. 2007 Oct-Dec;59(4):299-303. Italian.

13.

[Clinical analysis of 79 pulmonary arterial hypertension cases from 1892 connective tissue disease patients].

Lei YX, Zhang X, Cui Y, Dong GF, Luo RQ.

Zhonghua Yi Xue Za Zhi. 2009 Nov 10;89(41):2934-7. Chinese.

PMID:
20137654
14.

[Pulmonary arterial hypertension with connective tissue diseases].

Fukaya S, Yoshida S.

Nihon Rinsho. 2008 Nov;66(11):2200-4. Review. Japanese.

PMID:
19051743
15.

Long-term effects of intermittent Iloprost infusion on pulmonary arterial pressure in connective tissue disease.

Caravita S, Wu SC, Secchi MB, Dadone V, Bencini C, Pierini S.

Eur J Intern Med. 2011 Oct;22(5):518-21. doi: 10.1016/j.ejim.2011.02.005. Epub 2011 Mar 15.

PMID:
21925064
16.

[Clinical analysis of pulmonary arterial hypertension secondary to connective tissue disease in children].

Xing Y, Song HM, Wu XY, He YY, Wei M.

Zhonghua Er Ke Za Zhi. 2008 Nov;46(11):822-6. Chinese.

PMID:
19099898
17.

Immunosuppressive therapy in connective tissue diseases-associated pulmonary arterial hypertension.

Sanchez O, Sitbon O, Jaïs X, Simonneau G, Humbert M.

Chest. 2006 Jul;130(1):182-9.

PMID:
16840400
18.

Predictors of mortality in connective tissue disease-associated pulmonary arterial hypertension: a cohort study.

Ngian GS, Stevens W, Prior D, Gabbay E, Roddy J, Tran A, Minson R, Hill C, Chow K, Sahhar J, Proudman S, Nikpour M.

Arthritis Res Ther. 2012 Oct 5;14(5):R213. doi: 10.1186/ar4051.

19.

[Comparison of adenosine versus iloprost by acute vasodilator test in patients of pulmonary arterial hypertension complicated with connective tissue diseases].

Tian Z, Chen TB, Fang Q, Zeng XF, Liu YT, Li MT, Jiang XC, Gao P, Cheng KA, Wang Q.

Zhonghua Yi Xue Za Zhi. 2009 Aug 11;89(30):2099-102. Chinese.

PMID:
20058611
20.

Short-term and long-term epoprostenol (prostacyclin) therapy in pulmonary hypertension secondary to connective tissue diseases: results of a pilot study.

Humbert M, Sanchez O, Fartoukh M, Jagot JL, Le Gall C, Sitbon O, Parent F, Simonneau G.

Eur Respir J. 1999 Jun;13(6):1351-6.

Supplemental Content

Support Center